Maternal serum ADAM12 levels in Down and Edwards' syndrome pregnancies at 9-12 weeks' gestation

Prenatal Diagnosis

Volumn 26, Issue 8, 2006, Pages 689-691

  Laigaard, Jennie ^a,b   Cuckle, Howard ^c   Wewer, Ulla M ^b   Christiansen, Michael ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

ADAM12; Down syndrome; Edwards' syndrome; First trimester; Screening

Indexed keywords

A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 12; METALLOPROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; EDWARDS SYNDROME; FEMALE; FLUOROMETRY; GESTATION PERIOD; HUMAN; MAJOR CLINICAL STUDY; MATERNAL SERUM; PREGNANCY; PRIORITY JOURNAL; RANK SUM TEST;

ADAM PROTEINS; ADULT; BIOLOGICAL MARKERS; CHROMOSOMES, HUMAN, PAIR 18; DISINTEGRINS; DOWN SYNDROME; FEMALE; HUMANS; MEMBRANE PROTEINS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; REFERENCE VALUES; TRISOMY;

EID: 33747439633     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1480     Document Type: Article

References (12)

1. Avgidou K, Papageorghiou A, Bindra R, Spencer K, Nicolaides KH. 2005. Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies. Am J Obstet Gynecol 192: 1761-1767.
2. Christiansen M, Larsen SO. 2002. The design of first trimester maternal screening programmes for fetal chromosome anomalies: Increases in cost-effectiveness by contingent testing. Prenat Diagn 22: 482-486.
3. Christiansen M, Oxvig C, Wagner JM, et al. 1999. The proform of eosinophil major basic protein: a new maternal serum marker for Down syndrome. Prenat Diagn 19: 905-910.
4. Cuckle HS, Van Lith JM. 1999. Appropriate biochemical parameters in first-trimester screening for Down syndrome. Prenat Diagn 19: 505-512.
5. Cuckle H, Arbuzova S. 2004. Multianalyte maternal serum screening for chromosomal defects. In Genetic Disorders and the Fetus: Diagnosis, Prevention and Treatment (5th edn), Milunsky A (ed). Johns Hopkins University Press: Baltimore, USA; 795-835.
6. Laigaard J, Sorensen T, Frohlich C, et al. 2003. ADAM12: a novel first-trimester maternal serum marker for Down syndrome. Prenat Diagn 23: 1086-1091.
7. Laigaard J, Christiansen M, Frohlich C, Pedersen BN, Ottesen B, Wewer UM. 2005a. The level of ADAM12-S in maternal serum is an early first-trimester marker of fetal trisomy 18. Prenat Diagn 25: 45-46.
8. Laigaard J, Sorensen T, Placing S, et al. 2005b. Reduction of the disintegrin and metalloprotease ADAM12 in preeclampsia. Obstet Gynecol 106: 144-149.
9. Loechel F, Fox JW, Murphy G, Albrechtsen R, Wewer UM. 2000. ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-317. Biochem Biophys Res Commun 278: 511-515.
10. Qin QP, Christiansen M, Nguyen TH, Sorensen S, Larsen SO, Norgaard-Pedersen B. 1997. Schwangerschaftsprotein 1 (SP1) as a maternal serum marker for Down syndrome in the first and second trimesters. Prenat Diagn 17: 101-108.
11. Spencer K, Crossley JA, Aitken D, et al. 2002. Temporal changes in maternal serum biochemical markers of trisomy 21 across the first and second trimester of pregnancy. Ann Clin Biochem 39: 567-576.
12. Wald NJ, Watt HC, Norgaard-Pedersen B, Christiansen M. 1999. SP1 in pregnancies with Down syndrome in the first trimester of pregnancy. International prenatal screening research group. Prenat Diagn 19: 517-520.